Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

Clinical trial NCT05628883 · COMPLETED

Trial details

NCT number: NCT05628883
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma Unresectable Melanoma Acral Melanoma Mucosal Melanoma Cutaneous Melanoma Ocular Melanoma Uveal Melanoma Iris Melanoma Conjunctival Melanoma Non-Cutaneous Melanoma

Start date: 2022-11-22
Primary completion: 2024-12-03
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.